Comments on the article ‘Participation of the Czech population in colorectal cancer screening – trends and current situation’ in light of the National Colorectal Cancer Screening Programme in Slovakia

Czech version

Authors: M. Bátovský; R. Hrčka
Authors‘ workplace: Gastroenterolgická klinika SZU a UN Bratislava, Slovenská republika
Published in: Gastroent Hepatol 2017; 71(5): 384-387
Category: Commentary to the Articles

Sources

1. Národné centrum zdravotníckych informácií. Zdravotníctvo Slovenskej republiky 2014. Bratislava: Národné centrum zdravotníckych informácií 2016. [online]. Dostupné z: www.nczisk.sk.

2. Moss S, Mathews C, Day T et al. Increased participation in colorectal cancer screening during a pilot of faecal immunochemical test for haemoglobin (FIT) in England. Gut 2015; 64: 453–462. Abstract OC-002.

3. Zorzi M, Fedeli U, Schievano E et al. Impact on colorectal cancer mortality of screening programmmes based on the faecal immunochemical test. Gut 2015; 64 (5): 784–790. doi: 10.1136/gutjnl-2014-307 508.

4. Dušek L, Májek O, Mužík J et al. Epidemiologie a populační screening nádorů tlustého střeva a konečníku v České republice na podkladě nově dostupných dat. Gastroent Hepatol 2015; 69 (6): 509–517. doi: 10.14735/amgh2015509.

5. Vestník Ministerstva zdravotníctva Slovenskej republiky. Odborné usmernenie Ministerstva zdravotníctva Slovenskej republiky pre realizáciu programu skríningu kolorektálneho karcinómu. Vestník MZ SR 2011; 59 (26): 217–239.

6. Hrčka R, Bátovský M, Šutka J et al. Prepilotná štúdia skríningu kolorektálneho karcinómu pomocou i-TOKS na Slovensku. Gastroenterol Prax 2010; 9 (3): 131–135.

7. Hrčka R. Čo by sme mali vedieť skôr, než sa spustí Národný skríning KRK v SR? Lekárske listy – Onkológia 2010; 12: 3–10.

8. Van Roosbroeck S, Hoeck S, Van Hal G. Population-based screnning for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies. Cancer Epidemiol 2012; 36 (5): 317–324. doi: 10.1016/j.canep.2012.04.003.

9. Giorgi Rossi P, Grazzini G, Anti M et al. Direct mailing of faecal occult blood tests for colorectal cancer screening: a randomized population study from Central Italy. J Med Screen 2011; 18 (3): 121–127. doi: 10.1258/jms.2011.011009.

10. Tinmouth J, Patel J, Astin PC et al. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBt test to previous nonresponders. Int J Cancer 2015; 136 (6): E697–E703. doi: 10.1002/ijc.29191.

11. Courtier R, Casamitjana M, Macià et al. Participation in a colorectal cancer screening programme. Influence of the method of contacting the target population. Eur J Cancer Prev 2002; 11 (3): 209–213.

12. Ore L, Hagoel L, Lavi I et al. Screening with faecal occult blood test for colorectal cancer: assessment of two methods that attempt to improve compliance. Eur J Cancer Prev 2001; 10 (3): 251–256.

13. Wong MC, Ching JY, Chan VC et al. Informed choice vs no choice in colorectal cancer screening tests. A prospective cohort study in reallife screening practice. Am J Gastroenterol 2014; 109 (7): 1072–1079. doi: 10.1038/ajg.2014. 136.

14. Flight IH, Wilson CJ, Zajac IT et al. Decision support and the effectiveness of web-based delivery and information tailoring for bowel cancer screening: an exploratory study. JMIR Res Protoc 2012; 1 (2): 2–12. doi: 10.2196/resprot.2135.

15. Sequist TD, Zaslavsky AM, Marshall R et al. Patient and physician reminders to promote colorectal cancer screening. A randomized controlled trial. Arch Intern Med 2009; 169 (4): 364–371. doi: 10.1001/archinternmed.2008.564.

16. Arnold M, Sierra MS, Laversanne M et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut 2017; 66 (4): 683–691. doi: 10.1136/ gutjnl-2015-310912.